What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2022-05-09 compared with 2021-11-10 · 17 added, 23 removed, 20 unchanged (67% of the section changed)

Incorporation

Amended and Restated Certificate of Incorporation

Certificate of Designation of Series A Junior Participating Preferred Stock.

Certificate of Increase of Series A Junior Participating Preferred Stock.

Second Amended and Restated Stockholder Rights Plan

License Agreement, dated October 14, 2021, by and between Lipocine Inc.

and Antares Pharma, Inc.

Amendment No.

1 to Commercial Manufacturing Services and Supply Agreement between Lipocine Inc.

and MW Encap Ltd.

dated October 13, 2021

Amendment to License Agreement, dated October 14, 2021, made by and among Lipocine Inc., and Antares Pharma, Inc.

Accounting Officer Employment Agreement, dated March 7, 2022, by and between Lipocine Inc.

and Krista Fogarty.

Certification

13 unchanged sentences

XBRL Taxonomy Extension Presentation Linkbase Document

Page Interactive Data File––the cover page interactive data file does not appear in the Interactive Data File because

its XBRL tags are embedded within the Inline XBRL document.

portions of this exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K.

The Registrant hereby undertakes to furnish

to the SEC, upon request, copies of any such instruments.

certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and

is not to be incorporated by reference into any filing of the Registrant under the Securities Act, or the Exchange Act (whether made

before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Management contract or compensation

plan or arrangement

treatment has been granted with respect to certain portions of this exhibit.

Omitted portions have been submitted separately with

the Securities and Exchange Commission

certification accompanies the Form 10-Q to which it relates, is not deemed filed with the

Securities and Exchange Commission and is not to be incorporated by reference into any filing

of the Registrant under the Securities Act, or the Exchange Act (whether made before or after

the date of the Form 10-Q), irrespective of any general incorporation language contained

in such filing.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

November 10, 2021

Patel, President and Chief

Executive Officer)

November 10, 2021

Brown, Executive Vice President

Chief Financial Officer

Financial and Accounting Officer)

Krista Fogarty

Fogarty, Corporate Controller

Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information